We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Image Analysis Assesses Immune Reaction to Breast Cancer and Improves Treatment

By MedImaging International staff writers
Posted on 17 Mar 2015
Print article
A novel test has been developed that can be used to analyze images of “hotspots” where the immune system attacks breast cancer cells.

Scientists used statistical tests to help predict the survival chances of women with breast cancer by assessing the status of their immune system and treated only those in need of intensive treatment. Women with a high number of “hotspots” had a life expectancy of 91 months before their cancer spread while those with fewer hotspots lived 64 months on average.

The scientists analyzed tumor samples from 245 women with estrogen receptor negative (ER negative) breast cancer using computerized imaging and statistical analysis, and measured the number of immune cell hotspots where immune cells were spatially clustered around breast cancer cells. The hotspots were a better indicator of immune response than measuring the number of immune cells in a tumor.

The researchers at the Institute of Cancer Research (London, UK) published details of the test in the February 2015 issue of the journal Modern Pathology.

Team leader in Computational Pathology and Integrative Genomics at the ICR, Dr. Yinyin Yuan, said, “Our research is aiming to develop completely new ways of telling apart more and less aggressive cancers, based on how successful the immune system is in keeping tumors in check. We have shown that to measure the strength of an immune response to a cancer, we need to assess not just how many immune cells there are, but whether these are clustered together into cancer-busting hotspots. By analyzing the complex ways in which the immune system interacts with cancer cells, we can split women with breast cancer into two groups, who might need different types of treatment.”

Definiens (Munich, Germany), which provides image analysis for digital pathology and diagnostics, can discuss what this test means for patients as well as the industry, how this approach is being used in other cancers, challenges with studying the immune system and how they're being addressed, and other advancements expected in immune studies for cancer this year.

Related Links:

The Institute of Cancer Research 
Definiens 


Radiation Therapy Treatment Software Application
Elekta ONE
Diagnostic Ultrasound System
MS1700C
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Digital X-Ray Detector Panel
Acuity G4

Print article

Channels

MRI

view channel
Image: Comparison showing 3T and 7T scans for the same participant (Photo courtesy of P Simon Jones/University of Cambridge)

Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients

Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more

Ultrasound

view channel
Image: The new type of Sonogenetic EchoBack-CAR T cell (Photo courtesy of Longwei Liu/USC)

Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more